Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 1.48 trillion as of July 25, 2025. Its market cap has decreased by -4.95% in one year.

Market Cap

1.48T

Enterprise Value

1.47T

Revenue

141.00B

Ranking

n/a

PE Ratio

n/a

Stock Price

29,200.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.48T, an increase of 5,533.64%. That is a compound annual growth rate of 14.42%.

Market Cap History

Date	Market Cap	% Change
Jul 25, 2025	1,481.61B	-24.41%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	1,919.22B	3.31%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	77.44T
Celltrion	39.84T
ALTEOGEN	25.49T
Yuhan	9,219.06B
SK Biopharmaceuticals	7,987.95B
Peptron	6,628.10B
HLB Co., Ltd.	6,499.61B
PharmaResearch	6,015.61B

Market Cap Rankings